These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11731519)

  • 21. [A case of advanced adenocarcinoma of esophagogastric junction with severe esophageal invasion effectively treated by chemoradiotherapy using paclitaxel and cisplatin, and S-1 after chemoradiotherapy].
    Fujiwara H; Koeda K; Konosu M; Hosoi N; Tamasawa Y; Sase M; Tsukahara T; Ushio A; Taguchi M; Wakabayashi G
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1683-6. PubMed ID: 21996967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I/II study of trastuzumab, paclitaxel, cisplatin and radiation for locally advanced, HER2 overexpressing, esophageal adenocarcinoma.
    Safran H; Dipetrillo T; Akerman P; Ng T; Evans D; Steinhoff M; Benton D; Purviance J; Goldstein L; Tantravahi U; Kennedy T
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):405-9. PubMed ID: 17097832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation and management of pericardial effusion in patients with neoplastic disease.
    Maisch B; Ristic A; Pankuweit S
    Prog Cardiovasc Dis; 2010; 53(2):157-63. PubMed ID: 20728703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes from chemoradiotherapy for patients with esophageal cancer.
    Pantling AZ; Gossage JA; Mamidanna R; Newman G; Robinson A; Manifold DK; Hale PC
    Dis Esophagus; 2011 Apr; 24(3):172-6. PubMed ID: 21073614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pericardial and pleural effusions after definitive radiotherapy for esophageal cancer.
    Fukada J; Shigematsu N; Ohashi T; Shiraishi Y; Takeuchi H; Kawaguchi O; Kitagawa Y
    J Radiat Res; 2012; 53(3):447-53. PubMed ID: 22739014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial.
    Burmeister BH; Thomas JM; Burmeister EA; Walpole ET; Harvey JA; Thomson DB; Barbour AP; Gotley DC; Smithers BM
    Eur J Cancer; 2011 Feb; 47(3):354-60. PubMed ID: 21084184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Uterine cervical carcinoma and pericardial effusion].
    Vokaer B; Machiels JP; Vansnick F; Castaigne C; Feoli F; Dediste A; Sculier JP
    Rev Med Brux; 2007; 28(5):439-44. PubMed ID: 18069518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer.
    Rodriguez CP; Adelstein DJ; Rice TW; Rybicki LA; Videtic GM; Saxton JP; Murthy SC; Mason DP; Ives DI
    J Thorac Oncol; 2010 Feb; 5(2):229-35. PubMed ID: 20009775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of complete response to esophageal cancer by a novel concurrent chemoradiation therapy.
    Shimoyama S; Aoki F; Kojima J; Kaminishi M
    Hepatogastroenterology; 1999; 46(28):2409-13. PubMed ID: 10522007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
    Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R
    Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Malignant pericardial effusion after esophageal cancer surgery successfully treated by intrapericardial instillation of CDDP].
    Murata K; Iwazawa T; Doki Y; Inoue M; Kaneko T; Terashima T; Mizunoya S; Okagawa K
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2433-6. PubMed ID: 2665655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic significance of various methods for the recognition of pericardial effusion as examplified with a radiation-induced effusion following bronchial carcinoma].
    von Hohl H; Strödter D; Wick E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():370-4. PubMed ID: 611987
    [No Abstract]   [Full Text] [Related]  

  • 33. Toxicity of chemotherapy for esophageal carcinoma.
    Ilson D
    Chest Surg Clin N Am; 1997 Aug; 7(3):551-63; discussion 564. PubMed ID: 9246402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mediastinal lymphosarcoma complicated by recurrent hydropericardium].
    Kovalenko VL; Okhremchuk NI; Tiron KN
    Vestn Khir Im I I Grek; 1998; 157(6):80-2. PubMed ID: 10672671
    [No Abstract]   [Full Text] [Related]  

  • 35. [Tumors of the esophagus].
    Maillochaud JH; Nordlinger B
    Rev Prat; 2002 Jan; 52(1):91-7. PubMed ID: 11852774
    [No Abstract]   [Full Text] [Related]  

  • 36. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
    Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive pericardial effusion during chemotherapy for advanced Hodgkin lymphoma.
    Casey DJ; Kim AY; Olszewski AJ
    Am J Hematol; 2012 May; 87(5):521-4. PubMed ID: 22120982
    [No Abstract]   [Full Text] [Related]  

  • 38. [A case of stage IV (A3) cervical and upper thoracic esophageal adenocarcinoma successfully treated with concurrent chemoradiotherapy].
    Matsumoto G; Ise H; Inoue H; Suzuki N; Matsuo S
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2237-40. PubMed ID: 10635311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pericardial involvement in a non-Hodgkin lymphoma patient: coregistered FDG-PET and CT imaging.
    Weijs LE; Arsos G; Baarslag HJ; Wittebol S; de Klerk JM
    Eur Heart J; 2007 Nov; 28(22):2698. PubMed ID: 17567624
    [No Abstract]   [Full Text] [Related]  

  • 40. Pericardial effusion due to pericardium involvement by Hodgkin's lymphoma.
    Guastafierro S; Cappabianca S; Falcone U
    Ann Hematol; 2013 Jun; 92(6):853-4. PubMed ID: 23196418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.